Elliot Hampsey
Overview
Explore the profile of Elliot Hampsey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ulrichsen A, Hampsey E, Taylor R, Gadelrab R, Strawbridge R, Young A
BJPsych Open
. 2024 Nov;
10(6):e210.
PMID: 39534908
No abstract available.
2.
Pasha Memon H, Phiphopthatsanee N, Hampsey E
BJPsych Open
. 2024 Nov;
10(6):e206.
PMID: 39523666
Background: One of the 'critical goals' for psychiatric liaison services is reducing hospitalisation. Psychotropic medication is a treatment for psychosis, although research determining the efficacy of early medication administration is...
3.
Hampsey E, Jelen L, Young A
Expert Opin Emerg Drugs
. 2024 Apr;
29(3):193-204.
PMID: 38682267
Introduction: Major depression is a common, disabling mental health condition associated with the highest disease burden for any neuropsychiatric disorder worldwide, according to the WHO. Due to the imperfect efficacy...
4.
Hampsey E, Perkins A, Young A
Expert Opin Investig Drugs
. 2023 Mar;
32(4):277-282.
PMID: 36927202
Introduction: Anxiety disorders are common, disabling psychiatric conditions associated with excessive worry, irritability, and physiological symptoms of stress. Following insufficient response to psychological therapies, first-line pharmacological treatments for anxiety disorders...
5.
Scott F, Hampsey E, Gnanapragasam S, Carter B, Marwood L, Taylor R, et al.
J Psychopharmacol
. 2022 Jul;
37(3):268-278.
PMID: 35861202
Background: Major depressive disorder (MDD) is a highly burdensome health condition, for which there are numerous accepted pharmacological and psychological interventions. Adjunctive treatment (augmentation/combination) is recommended for the ~50% of...
6.
Hampsey E, Meszaros M, Skirrow C, Strawbridge R, Taylor R, Chok L, et al.
BMJ Open
. 2022 Jun;
12(6):e061193.
PMID: 35667724
Introduction: Neurodegenerative and psychiatric disorders (NPDs) confer a huge health burden, which is set to increase as populations age. New, remotely delivered diagnostic assessments that can detect early stage NPDs...
7.
Walker J, van Niekerk M, Hobbs H, Toynbee M, Magill N, Bold R, et al.
Gen Hosp Psychiatry
. 2021 Aug;
72:131-140.
PMID: 34454342
Objective: To determine the prevalence of anxiety in general hospital inpatients by conducting a systematic review and meta-analysis of all relevant published studies. Method: We searched Ovid Medline, Ovid Embase...
8.
Hampsey E, Overton P, Stafford T
J Eye Mov Res
. 2021 Apr;
12(6).
PMID: 33828750
In 22 human subjects we measured microsaccade count across 60 brief fixation trials both pre- and post- administration of 300mg of caffeine. There was a statistically significant reduction in average...